New Rotavirus Vaccine Close to Launch in Mexico
Mon Jul 5, 2004 04:21 PM ET
By Lorraine Orlandi
MEXICO CITY (Reuters) - A new vaccine against rotavirus, one of the world's chief killers of children, is due to be launched in Mexico as soon as this year and will mark a sea change in how major companies market drugs worldwide.
GlaxoSmithKline submitted its oral vaccine Rotarix to Mexican authorities for approval and conducted clinical trials with more than 60,000 children in one of the largest such studies ever, Dr. Bruce Innis, vice president for Latin America research and development at GSK, said in a telephone interview on Monday.
In launching the vaccine in Mexico, the company "reverses the history of vaccine development in the last 50 years, in which new products are introduced in the United States
Article: http://www.reuters.com/printerFriendlyPopup.jhtml?type=healthNews&storyID=5590293